Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression? (Q53518964)

15 May 2018

title

Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression? (English)

1 reference

15 May 2018

author name string

J M Fernández-Cebrián

1

1 reference

15 May 2018

M Nevado Santos

2

1 reference

15 May 2018

P Vorwald Kuborn

3

1 reference

15 May 2018

M Pardo de Lama

4

1 reference

15 May 2018

J Martín-Cavanna

5

1 reference

15 May 2018

P Pacheco Martínez

6

1 reference

15 May 2018

B Fernández Escudero

7

1 reference

15 May 2018

M Ramos Fernández

8

1 reference

15 May 2018

publication date

1 October 2007

1 reference

15 May 2018

Clinical and Translational Oncology

published in

1 reference

15 May 2018

volume

9

1 reference

15 May 2018

issue

10

1 reference

15 May 2018

page(s)

663-670

1 reference

15 May 2018

Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-007-0119-Z

Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

12 December 2020

A model for p53-induced apoptosis

1 reference

12 December 2020

Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?

1 reference

12 December 2020

Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

1 reference

12 December 2020

Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases

1 reference

12 December 2020

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

1 reference

12 December 2020

Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel

1 reference

12 December 2020

Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery

1 reference

12 December 2020

DNA ploidy as a significant prognostic factor after radical resection for large bowel carcinoma: a prospective study

1 reference

12 December 2020

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

1 reference

12 December 2020

Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer

1 reference

12 December 2020

Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis

1 reference

12 December 2020

Stage II colon cancer prognosis prediction by tumor gene expression profiling

1 reference

12 December 2020

Current issues in adjuvant treatment of stage II colon cancer

1 reference

12 December 2020

Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization

1 reference

12 December 2020

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

12 December 2020

Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas

1 reference

12 December 2020

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

1 reference

12 December 2020

Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma

1 reference

12 December 2020

Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer

1 reference

12 December 2020

Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).

1 reference

12 December 2020

Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis

1 reference

12 December 2020

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

1 reference

12 December 2020

The results of colorectal cancer treatment by p53 status: treatment-specific overview

1 reference

12 December 2020

Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases

1 reference

12 December 2020

Genetic alterations during colorectal-tumor development

1 reference

12 December 2020

Counting alleles to predict recurrence of early-stage colorectal cancers

1 reference

12 December 2020

Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer.

1 reference

12 December 2020

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

1 reference

12 December 2020

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation

1 reference

12 December 2020

Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor in colorectal adenocarcinoma

1 reference

12 December 2020

10.1007/S12094-007-0119-Z

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018